FOOD
AND DRUG ADMINISTRATION
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE
MEETING ON INFLUENZA VIRUS VACCINE FORMULATION FOR
2002-2003
AND CBER LABORATORY SITE VISIT FOR LHV AND LVBVD
MEETING BY TELECONFERENCE
AGENDA
WEDNESDAY, MARCH 6, 2002
BUILDING
29, ROOM 121
Bethesda, Maryland
12:30 PM EST
| 12:30 PM | Call to Order | Dr.Daum, Committee Chair |
| 12:35 | Announcements | Dr. Jody Sachs, FDA |
| 12:40 | Session 1- Open Session Strain Selection for the Influenza Virus Vaccines for 2002-2003 |
|
| Introduction and Review | Dr. Levandowski, FDA | |
| Additional Information, A H3N2 and B Viruses | ||
| Dr. Nancy Cox, CDC Dr. Levandowski, FDA |
||
| 1:30 | Committee Discussion | |
| 2:00 | Open Public Hearing for Session 1 | |
| 2:30 | Recommendations for Influenza Virus Vaccine for 2002-2003 | |
| 2:45 | Session 2-Open Session Brief Overview of the CBER Laboratories that underwent Site Visit: |
|
| Overview of the Division of Viral Products | Dr. Jerry Weir | |
| 2:50 | Synopsis of Laboratory of Hepatitis Virus (LHV) | Dr. Stephen Feinstone |
| 3:05 | Synopsis of Laboratory of Vector-borne Viral Diseases (LVVD) | |
| Dr. Lewis Markoff | ||
| 3:20 | Open Public Hearing for Session 2 | |
| 3:50 | Session 3-Closed Session | Dr. Stanley Lemon |
| Site Visit Report Discussion and Committee Recommendations | ||
| 4:50 | Adjournment | |